Detalles de la búsqueda
1.
Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
Clin Sci (Lond)
; 135(22): 2559-2573, 2021 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778899
2.
Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis.
Mod Pathol
; 33(3): 380-390, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527709
3.
Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma.
Eur Respir J
; 54(5)2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31391226
4.
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.
Ann Rheum Dis
; 73(1): 256-62, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23434567
5.
Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis.
Rheumatology (Oxford)
; 53(4): 686-95, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357810
6.
Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety.
Toxicol Appl Pharmacol
; 279(2): 230-9, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24937321
7.
Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.
Toxicol Pathol
; 42(4): 725-64, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24705884
8.
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Target Oncol
; 19(3): 321-332, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683495
9.
Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.
J Infect Dis
; 205(8): 1311-20, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22262795
10.
The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies.
Sci Rep
; 12(1): 13876, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974054
11.
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.
Lancet Gastroenterol Hepatol
; 7(6): 522-532, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278356
12.
Domain Adaptation-Based Deep Learning for Automated Tumor Cell (TC) Scoring and Survival Analysis on PD-L1 Stained Tissue Images.
IEEE Trans Med Imaging
; 40(9): 2513-2523, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003747
13.
Optimal PD-L1-high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy.
PLoS One
; 15(4): e0231936, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32339189
14.
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414858
15.
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma.
Clin Cancer Res
; 26(4): 846-854, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31676670
16.
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma.
Diagn Pathol
; 14(1): 99, 2019 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31477145
17.
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy.
J Immunother Cancer
; 7(1): 121, 2019 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060602
18.
Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma.
Arch Pathol Lab Med
; 143(6): 722-731, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30457897
19.
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens.
J Vis Exp
; (143)2019 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30735177
20.
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
Eur J Cancer
; 109: 154-161, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30731276